Press Releases

Month Year

Month Year

Apr 27, 2022

Evofem Improves Phexxi® Patient Experiences Through New Agreement with VitaCare Prescription Services
Apr 26, 2022

Evofem to Present New Research in Gynecological Health at the 2022 American College of Obstetricians and Gynecologists Annual Meeting
Apr 25, 2022

Evofem Biosciences to Report First Quarter 2022 Results and Provide Corporate Update on Wednesday, May 4, 2022
Apr 19, 2022

Journal of Sexual Medicine Publishes Sexual Satisfaction Data Involving Phexxi® from Evofem's Phase 3 AMPOWER Clinical Trial
Apr 11, 2022

Evofem Announces Karina Fedasz as Company's New Head of Business Development
Apr 7, 2022

Nasdaq Accepts Evofem Plan to Regain Listing Compliance
Mar 31, 2022

Evofem Presents Positive Encore Data in Sexually Transmitted Infections Impacting Women at the 2022 Academy of Managed Care Pharmacy Annual Meeting
Mar 4, 2022

Evofem Completes Enrollment in EVOGUARD Phase 3 Clinical Trial of EVO100 for Prevention of Chlamydia and Gonorrhea in Women

-- EVOGUARD remains on track for topline data readout later this year
Mar 3, 2022

Evofem Biosciences Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update

-- Net product sales more than doubled in the fourth quarter of 2021 vs. third quarter of 2021 --
Feb 17, 2022

Evofem Biosciences to Report Fourth Quarter and Year-End 2021 Results and Provide Corporate Update on Thursday, March 3, 2022

-- Conference Call Scheduled for 4:30 p.m. ET -

Show per page